Variability of adiposity indices and incident heart failure among adults with type 2 diabetes. 2022

Arnaud D Kaze, and Sebhat Erqou, and Prasanna Santhanam, and Alain G Bertoni, and Rexford S Ahima, and Gregg C Fonarow, and Justin B Echouffo-Tcheugui
Department of Medicine, SOVAH Health, Danville, VA, USA.

It remains unclear how the variability of adiposity indices relates to incident HF. This study evaluated the associations of the variability in several adiposity indices with incident heart failure (HF) in individuals with type 2 diabetes (T2DM). We included 4073 participants from the Look AHEAD (Action for Health in Diabetes) study. We assessed variability of body mass index (BMI), waist circumference (WC), and body weight across four annual visits using three variability metrics, the variability independent of the mean (VIM), coefficient of variation (CV), and intraindividual standard deviation (SD). Multivariable Cox regression models were used to generate adjusted hazard ratios (aHR) and 95% confidence intervals (CI) for incident HF. Over a median of 6.7 years, 120 participants developed incident HF. After adjusting for relevant confounders including baseline adiposity levels, the aHR for the highest (Q4) versus lowest quartile (Q1) of VIM of BMI was 3.61 (95% CI 1.91-6.80). The corresponding aHRs for CV and SD of BMI were 2.48 (95% CI 1.36-4.53) and 2.88 (1.52-5.46), respectively. Regarding WC variability, the equivalent aHRs were 1.90 (95% CI 1.11-3.26), 1.79 (95% CI 1.07-3.01), and 1.73 (1.01-2.95) for Q4 versus Q1 of VIM, CV and SD of WC, respectively. In a large sample of adults with T2DM, a greater variability of adiposity indices was associated with higher risks of incident HF, independently of traditional risk factors and baseline adiposity levels. Registration-URL: https://clinicaltrials.gov/ct2/show/NCT00000620 .

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Arnaud D Kaze, and Sebhat Erqou, and Prasanna Santhanam, and Alain G Bertoni, and Rexford S Ahima, and Gregg C Fonarow, and Justin B Echouffo-Tcheugui
February 2022, The Journal of clinical endocrinology and metabolism,
Arnaud D Kaze, and Sebhat Erqou, and Prasanna Santhanam, and Alain G Bertoni, and Rexford S Ahima, and Gregg C Fonarow, and Justin B Echouffo-Tcheugui
December 2022, Diabetes care,
Arnaud D Kaze, and Sebhat Erqou, and Prasanna Santhanam, and Alain G Bertoni, and Rexford S Ahima, and Gregg C Fonarow, and Justin B Echouffo-Tcheugui
April 2014, The New England journal of medicine,
Arnaud D Kaze, and Sebhat Erqou, and Prasanna Santhanam, and Alain G Bertoni, and Rexford S Ahima, and Gregg C Fonarow, and Justin B Echouffo-Tcheugui
April 2014, The New England journal of medicine,
Arnaud D Kaze, and Sebhat Erqou, and Prasanna Santhanam, and Alain G Bertoni, and Rexford S Ahima, and Gregg C Fonarow, and Justin B Echouffo-Tcheugui
April 2014, The New England journal of medicine,
Arnaud D Kaze, and Sebhat Erqou, and Prasanna Santhanam, and Alain G Bertoni, and Rexford S Ahima, and Gregg C Fonarow, and Justin B Echouffo-Tcheugui
April 2014, The New England journal of medicine,
Arnaud D Kaze, and Sebhat Erqou, and Prasanna Santhanam, and Alain G Bertoni, and Rexford S Ahima, and Gregg C Fonarow, and Justin B Echouffo-Tcheugui
April 2014, The New England journal of medicine,
Arnaud D Kaze, and Sebhat Erqou, and Prasanna Santhanam, and Alain G Bertoni, and Rexford S Ahima, and Gregg C Fonarow, and Justin B Echouffo-Tcheugui
September 2021, Journal of the American Heart Association,
Arnaud D Kaze, and Sebhat Erqou, and Prasanna Santhanam, and Alain G Bertoni, and Rexford S Ahima, and Gregg C Fonarow, and Justin B Echouffo-Tcheugui
September 2023, The Journal of clinical endocrinology and metabolism,
Arnaud D Kaze, and Sebhat Erqou, and Prasanna Santhanam, and Alain G Bertoni, and Rexford S Ahima, and Gregg C Fonarow, and Justin B Echouffo-Tcheugui
August 2011, Pharmacoepidemiology and drug safety,
Copied contents to your clipboard!